Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle David

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Rheumatology|January 29, 2022
Mortality associated with Behçet's disease in France assessed by multiple-cause-of-death analysisEmmanuelle David, Mathieu Fauvernier, David Saadoun, et al.
The American Journal of Pathology|September 18, 2012
Oncostatin M is a growth factor for Ewing sarcomaEmmanuelle David, Franck Tirode, Marc Baud'huin, et al.
Journal of Clinical Medicine|July 27, 2022
Human Papilloma Virus Vaccination in Patients with Rheumatic Diseases in France: A Study of Vaccination Coverage and Drivers of VaccinationEmmanuelle David, Pascal Roy, Alexandre Belot, et al.
Bone|January 27, 2009
Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cellsBénédicte Brounais, Emmanuelle David, Céline Chipoy, et al.
Stem Cells (Dayton, Ohio)|January 24, 2012
Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signalingPierre Guihard, Yannic Danger, Bénédicte Brounais, et al.
EJNMMI Research|May 22, 2013
99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic modelElisabeth Miot-Noirault, Emmanuelle David, Aurélien Vidal, et al.
Oncotarget|November 27, 2020
Phase I dose escalation study of 12b80 (hydroxybisphosphonate linked doxorubicin) in naturally occurring osteosarcomaPierre Boyé, Emmanuelle David, François Serres, et al.
International Journal of Cancer|February 24, 2011
Direct anti-cancer effect of oncostatin M on chondrosarcomaEmmanuelle David, Pierre Guihard, Bénédicte Brounais, et al.
Investigational New Drugs|April 19, 2011
Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studiesCaroline Peyrode, Valérie Weber, Emmanuelle David, et al.
Bioconjugate Chemistry|May 3, 2019
12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of OsteosarcomaEmmanuelle David, Sébastien Cagnol, Jean-Yves Goujon, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Rheumatology|January 29, 2022
Mortality associated with Behçet's disease in France assessed by multiple-cause-of-death analysisEmmanuelle David, Mathieu Fauvernier, David Saadoun, et al.
The American Journal of Pathology|September 18, 2012
Oncostatin M is a growth factor for Ewing sarcomaEmmanuelle David, Franck Tirode, Marc Baud'huin, et al.
Journal of Clinical Medicine|July 27, 2022
Human Papilloma Virus Vaccination in Patients with Rheumatic Diseases in France: A Study of Vaccination Coverage and Drivers of VaccinationEmmanuelle David, Pascal Roy, Alexandre Belot, et al.
Bone|January 27, 2009
Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cellsBénédicte Brounais, Emmanuelle David, Céline Chipoy, et al.
Stem Cells (Dayton, Ohio)|January 24, 2012
Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signalingPierre Guihard, Yannic Danger, Bénédicte Brounais, et al.
EJNMMI Research|May 22, 2013
99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic modelElisabeth Miot-Noirault, Emmanuelle David, Aurélien Vidal, et al.
Oncotarget|November 27, 2020
Phase I dose escalation study of 12b80 (hydroxybisphosphonate linked doxorubicin) in naturally occurring osteosarcomaPierre Boyé, Emmanuelle David, François Serres, et al.
International Journal of Cancer|February 24, 2011
Direct anti-cancer effect of oncostatin M on chondrosarcomaEmmanuelle David, Pierre Guihard, Bénédicte Brounais, et al.
Investigational New Drugs|April 19, 2011
Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studiesCaroline Peyrode, Valérie Weber, Emmanuelle David, et al.
Bioconjugate Chemistry|May 3, 2019
12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of OsteosarcomaEmmanuelle David, Sébastien Cagnol, Jean-Yves Goujon, et al.
Pageof 2